Pyrazolopyrimidines Establish MurC as a Vulnerable Target in Pseudomonas aeruginosa and Escherichia coli-Reference-Cited by-同舟云学术

Pyrazolopyrimidines Establish MurC as a Vulnerable Target in Pseudomonas aeruginosa and Escherichia coli

Published:2014-08-05 Issue:10 Volume:9 Page:2274-2282
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Hameed P Shahul¹,Manjrekar Praveena¹,Chinnapattu Murugan¹,Humnabadkar Vaishali¹,Shanbhag Gajanan¹,Kedari Chaitanyakumar¹,Mudugal Naina Vinay¹,Ambady Anisha¹,de Jonge Boudewijn L.M.²,Sadler Claire³,Paul Beena¹,Sriram Shubha²,Kaur Parvinder¹,Guptha Supreeth¹,Raichurkar Anandkumar¹,Fleming Paul²,Eyermann Charles J.²,McKinney David C.²,Sambandamurthy Vasan K.¹,Panda Manoranjan¹,Ravishankar Sudha¹

Affiliation:

1. Innovative Medicines, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore 560024, India

2. AstraZeneca Infection, Innovative Medicines, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States

3. Global Safety Assessment, AstraZeneca, Alderley Park, Mereside, Cheshire, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/cb500360c

Reference44 articles.

1. Antibiotic resistance—the need for global solutions